Note 3 – Stockholders’ Equity and Share-Based Compensation

Options and Restricted Stock Units

The Company had the following common stock option activity during the thirty-nine weeks ended September 30, 2023:

The following table summarizes the Company’s restricted stock unit ("RSU") activity for the thirty-nine weeks ended September 30, 2023, and details regarding the awards outstanding and exercisable as of September 30, 2023 (in thousands):

​

During the thirty-nine weeks ended September 30, 2023, 756 RSUs that vested were time-based and 276 were performance-based.

For the thirteen and thirty-nine weeks ended September 30, 2023, we recorded compensation costs related to stock options and RSUs of $1,640 and $8,747, respectively. For the thirteen and thirty-nine weeks ended October 1, 2022, we recorded compensation costs related to stock options and RSUs of $3,760 and $8,837, of which $0 and $81 related to common shares issued to consultants as part of their compensation for services provided during those respective periods. As of September 30, 2023, there was unrecognized compensation expense related to stock options and RSUs of $21,325 that will be expensed through September 2027.

Stock Repurchase Program

On July 27, 2021, the Company’s Board of Directors authorized a stock repurchase program under which the Company may purchase up to $30 million of the Company’s common stock from time to time. The repurchases of common stock may be executed through open market purchases, block trades, the implementation of a 10b5-1 plan, and/or any other available methods. During the thirteen weeks ended September 30, 2023, the Company repurchased 245 shares of its common stock at a total cost of $1,094, excluding commissions, at an average price of $4.47. During the thirty-nine weeks ended September 30, 2023, the Company repurchased 495 shares of its common stock at a total cost of $2,141, excluding commissions, at an average price of $4.33 per share. During the thirteen and thirty-nine weeks ended October 1, 2022, the Company did not repurchase any shares of its common stock. As of September 30, 2023, the Company remained authorized to repurchase up to approximately $27,379 in shares of its common stock.